Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
AOC opts out of House Oversight leadership race, highlighting ongoing debates within the Democratic caucus about seniority and leadership renewal.
Henry Schein misses Q1 revenue, but KKR takes stake, influencing board composition.
Trump signs executive actions to boost domestic drug manufacturing and oversight of gain-of-function research, raising concerns over potential higher costs and shortages.
AOC opts out of House Oversight leadership race, highlighting ongoing debates within the Democratic caucus about seniority and leadership renewal.